06-13-2018 04:35 PM CET - Health & Medicine
Print

Future of Peptide and Heparin Market: Trends, Share, Growth and Forecast Report 2017-26

Press release from: Fact.MR
Fact.MR
Fact.MR
The rapidly expanding peptide and heparin market is the focus of a new report added to the market intelligence repository of Fact.MR. This 170-page broad study is headlined as “Peptide and Heparin Market Research Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2026” which noticeably examines the prospects of the global peptide and heparin industry till the end of 2022, using the market’s development trajectory in the recent past as the key indicator of actionable insights into the market’s growth pattern. A blend of primary & secondary research has been implemented for offering estimates and forecasts on the concerned market.

Request Sample Report@ www.factmr.com/connectus/sample?flag=S&rep_id=378

Drug Developers Shifting Back to Peptides owing to Mounting Challenges regarding Small Molecules

While the pharmaceutical sector discerned small molecules as the medicinal agents, therapeutic peptides were considered to be niche products. However, with mounting challenges regarding small molecules, drug developers are shifting their concentration back to small amino acid chains. Although peptides have been deemed ineffective for developing drugs, modern peptide drug designs and formulations have been developed for circumventing their weaknesses. For example, original requirement for injecting peptides such as insulin is fading, with more patient-friendly administrations progressively being developed. In addition, the current society that critically judges undesirable effects and environmental impact of the candidate medicines is embracing the safety offered by peptides.

Heparin is being extensively employed as an antitumor and anti-inflammatory agent. The anti-inflammatory characteristic of heparin, which prevents metastatic spreading of tumor cells, is a new research finding among healthcare professionals. The metastatic spreading of tumor cells is restricted by heparin through neutralization of cationic mediators, inhibition of heparanase, and adhesion molecules. Recent discoveries have meant that heparin is capable of targeting L- and P-selectin & integrin activity, as well as preventing cancer progression.

APEJ to Remain Most Remunerative Market for Peptide and Heparin

There has been a growing demand for new oral anticoagulants having better efficacy and safety profiles in Asia-Pacific excluding Japan (APEJ). Side effects related to heparin products, including complications of bleeding and heparin-induced thrombocytopenia has resulted into robust adoption of oral anticoagulants in the region. In addition, rising incidence of cancer, metabolic disorders, and hepatitis, along with advancements in peptide synthesis technology and rapid demand for various peptide therapies in the region are expected to drive the growth in APEJ. APEJ will remain the most remunerative market for peptide and heparin.

Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.

View Report@ www.factmr.com/report/378/peptides-heparin-market

Table of Contents:

Global Economic Outlook
Global Peptide and Heparin Market – Executive Summary
Global Peptide and Heparin Market Overview
3.1. Introduction
3.1.1. Global Peptide and Heparin Market Taxonomy
3.1.2. Global Peptide and Heparin Market Definition
3.2. Global Peptide and Heparin Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Peptide and Heparin Market Y-o-Y Growth
3.3. Global Peptide and Heparin Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTLE Analysis
3.7. Product Lifecycle
3.8. List of Distributors
3.9. Key Participants Market Presence (Intensity Map) By Region
Global Peptide and Heparin Market Analysis and Forecast 2012-2026
4.1. Global Peptide and Heparin Market Size and Forecast By Product Type , 2012-2026
4.1.1. Sodium Heparin Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
Continued……..

Check Discount on this Report@ www.factmr.com/connectus/sample?flag=D&rep_id=378

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/

This release was published on openPR.
News-ID: 1081335 • Views: 120
More releases More releases

You can edit or delete your press release here: